Cancer Cell Panel Screening

Creative Bioarray specializes in high-throughput cancer cell panel screening, a valuable tool in drug development. Our services include examining large panels of cancer cell lines to determine the effectiveness and toxicity of potential oncology therapeutics.

By identifying sensitive and resistant cells, we can better understand drug responses and aid in patient stratification for drug candidates and combinations. Additionally, our bioinformatics analysis allows us to link molecular features with phenotypic response, providing valuable insights into the underlying genomic factors influencing drug efficacy.

Choose Creative Bioarray for optimized high-throughput phenotypic screening and drug profiling to accelerate your drug development process.

• Comprehensive, high-throughput, and cost-effective cell line screening services
• 600+ cancer cell lines readily utilized for the single agent or combinatory drug screening
• Screen in 2D and 3D models, spheroids or organoids
• Integrated with downstream pharmacological services, with CDX models ready-for-use